Personal information

Keywords

Cancer, Survival analysis

Activities

Collapse all

Employment (3)

London School of Hygiene & Tropical Medicine: London, London, GB

2020-06-01 to present | Assistant Professor (Inequalities in Cancer Outcomes Network)
Employment
Source: Self-asserted source
Camille Maringe

London School of Hygiene and Tropical Medicine: London, London, GB

2007-11-01 to present | Research Fellow (CRUK Cancer Survival Group)
Employment
Source: Self-asserted source
Camille Maringe

GlaxoSmithKline Plc: Brentford, London, GB

2006-04-30 to 2007-10-07 (Epidemiology)
Employment
Source: Self-asserted source
Camille Maringe

Education and qualifications (2)

ENSAI: Bruz, Brittany, FR

2004-09-01 to 2006-04-29
Education
Source: Self-asserted source
Camille Maringe

Université Paris Dauphine: Paris, Île-de-France, FR

2000-09-01 to 2004-08-31
Education
Source: Self-asserted source
Camille Maringe

Works (13)

Target trial emulation with multi-state model analysis to assess treatment effectiveness using clinical COVID-19 data

BMC Medical Research Methodology
2023-09-02 | Journal article
DOI: 10.1186/s12874-023-02001-8
Contributors: Oksana Martinuka; Derek Hazard; Hamid Reza Marateb; Camille Maringe; Marjan Mansourian; Manuel Rubio-Rivas; Martin Wolkewitz
Source: check_circle
Crossref

Immortal time bias in older vs younger age groups: a simulation study with application to a population-based cohort of patients with colon cancer

2022-03-13 | Preprint
DOI: 10.1101/2022.03.11.22272268
Contributors: Sophie Pilleron; Camille Maringe; Eva JA Morris; Clémence Leyrat
Source: check_circle
Crossref

Introduction to computational causal inference using reproducible Stata, R, and Python code: A tutorial

Statistics in Medicine
2022-01-30 | Journal article
DOI: 10.1002/sim.9234
Contributors: Matthew J. Smith; Mohammad A. Mansournia; Camille Maringe; Paul N. Zivich; Stephen R. Cole; Clémence Leyrat; Aurélien Belot; Bernard Rachet; Miguel A. Luque‐Fernandez
Source: check_circle
Crossref

Reply to: Versatility of the clone-censor-weight approach: response to ‘‘trial emulation in the presence of immortal-time bias’’

International Journal of Epidemiology
2021-05-17 | Journal article
DOI: 10.1093/ije/dyaa225
Contributors: Camille Maringe; Sara Benitez Majano; Aimilia Exarchakou; Matthew Smith; Bernard Rachet; Aurélien Belot; Clémence Leyrat
Source: check_circle
Crossref

Prediction of cancer survival for cohorts of patients most recently diagnosed using multi-model inference

Statistical Methods in Medical Research
2020-12 | Journal article
DOI: 10.1177/0962280220934501
Contributors: Camille Maringe; Aurélien Belot; Bernard Rachet
Source: check_circle
Crossref

Age disparities in lung cancer survival in New Zealand: the role of patient and clinical factors

2020-10-06 | Other
DOI: 10.1101/2020.10.05.20206912
Contributors: Sophie Pilleron; Camille Maringe; Hadrien Charvat; June Atkinson; Eva Morris; Diana Sarfati
Source: check_circle
Crossref

Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data

International Journal of Epidemiology
2020-10-01 | Journal article
DOI: 10.1093/ije/dyaa057
Contributors: Camille Maringe; Sara Benitez Majano; Aimilia Exarchakou; Matthew Smith; Bernard Rachet; Aurélien Belot; Clémence Leyrat
Source: check_circle
Crossref

<p>Summarizing and Communicating on Survival Data According to the Audience: A Tutorial on Different Measures Illustrated with Population-Based Cancer Registry Data [Corrigendum]</p>

Clinical Epidemiology
2020-08 | Journal article
DOI: 10.2147/CLEP.S273165
Contributors: Aurélien Belot; Aminata Ndiaye; Miguel-Angel Luque-Fernandez; Dimitra-Kleio Kipourou; Camille Maringe; Francisco Javier Rubio; Bernard Rachet
Source: check_circle
Crossref

Comparison of model-building strategies for excess hazard regression models in the context of cancer epidemiology

BMC Medical Research Methodology
2019-12 | Journal article
DOI: 10.1186/s12874-019-0830-9
Contributors: Camille Maringe; Aurélien Belot; Francisco Javier Rubio; Bernard Rachet
Source: check_circle
Crossref

Summarizing and communicating on survival data according to the audience: a tutorial on different measures illustrated with population-based cancer registry data

Clinical Epidemiology
2019-01 | Journal article
DOI: 10.2147/CLEP.S173523
Contributors: Aurélien Belot; Aminata Ndiaye; Miguel-Angel Luque-Fernandez; Dimitra-Kleio Kipourou; Camille Maringe; Francisco Javier Rubio; Bernard Rachet
Source: check_circle
Crossref

Trends in lung cancer emergency presentation in England, 2006–2013: is there a pattern by general practice?

BMC Cancer
2018-12 | Journal article
DOI: 10.1186/s12885-018-4476-5
Contributors: Camille Maringe; Nora Pashayan; Francisco Javier Rubio; George Ploubidis; Stephen W. Duffy; Bernard Rachet; Rosalind Raine
Source: check_circle
Crossref

Explained variation of excess hazard models

Statistics in Medicine
2018-06-30 | Journal article
DOI: 10.1002/sim.7645
Contributors: Camille Maringe; Maja Pohar Perme; Janez Stare; Bernard Rachet
Source: check_circle
Crossref

Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities

PLOS ONE
2017-03-06 | Journal article
DOI: 10.1371/journal.pone.0172814
Contributors: Camille Maringe; Siew Hua Gan; Helen Fowler; Bernard Rachet; Miguel Angel Luque-Fernandez
Source: check_circle
Crossref

Peer review (2 reviews for 2 publications/grants)

Review activity for British journal of cancer. (1)
Review activity for Thorax (1)
How many people are using ORCID?